Infective Endocarditis in North Africa and the Middle East, 1990‒2019: Updates from the Global Burden of Disease Study 2019.

Humans Male Female Africa, Northern / epidemiology Global Burden of Disease Middle East / epidemiology Middle Aged Adult Child Aged Child, Preschool Incidence Adolescent Young Adult Infant Disability-Adjusted Life Years Endocarditis / epidemiology Prevalence Sex Distribution Age Distribution Aged, 80 and over Infant, Newborn

Africa Burden of disease Endocarditis Epidemiology Middle East Northern

Journal

Archives of Iranian medicine

ISSN: 1735-3947

Titre abrégé: Arch Iran Med

Pays: Iran

ID NLM: 100889644

Informations de publication

Date de publication:
01 May 2024

Historique:

received: 27 01 2024

accepted: 09 03 2024

medline: 1 5 2024

pubmed: 1 5 2024

entrez: 1 5 2024

Statut: epublish

Résumé

Infective endocarditis (IE), a severe and economically impactful condition, lacks substantial epidemiological data in the North Africa and Middle East (NAME) region. This study focused on analyzing the trends and burden of IE in NAME from 1990 to 2019, taking into account factors like age, gender, and socio-demographic index (SDI). The Global Burden of Disease data from 1990 to 2019 was retrieved from the Institute for Health Metrics and Evaluation (IHME) website. Between 1990 and 2019, the age-standardized rates (ASR) for IE incidence increased by 59%, and prevalence and years lived with disability (YLDs) rose by 12% and 9%, respectively, while the ASRs for deaths, disability-adjusted life years (DALYs), and years of life lost (YLLs) saw reductions of 22%, 34%, and 34% in the NAME region. Death rates among children under five declined by 72%. Gender and the SDI did not significantly influence these changes. Saudi Arabia witnessed the most significant increase in ASR of IE incidence since 1990, while Turkey had the highest rates in 2019. The year 2019 also saw the highest death rate among those aged 70 and over, with over 91000 DALYs from IE. DALYs decreased by 71.5% for children under five from 1990 to 2019 but remained stable for individuals in their seventies. Jordan showed the most notable decrease in ASRs for deaths, DALYs, and YLLs among children under five. This study highlights the changing epidemiology of IE in the NAME region, recommending the establishment of multidisciplinary IE registries, antibiotic prophylaxis guidelines for healthcare-associated IE, and strategies to control antimicrobial resistance as key mitigation measures.

Sections du résumé

BACKGROUND BACKGROUND

METHODS METHODS

The Global Burden of Disease data from 1990 to 2019 was retrieved from the Institute for Health Metrics and Evaluation (IHME) website.

RESULTS RESULTS

Between 1990 and 2019, the age-standardized rates (ASR) for IE incidence increased by 59%, and prevalence and years lived with disability (YLDs) rose by 12% and 9%, respectively, while the ASRs for deaths, disability-adjusted life years (DALYs), and years of life lost (YLLs) saw reductions of 22%, 34%, and 34% in the NAME region. Death rates among children under five declined by 72%. Gender and the SDI did not significantly influence these changes. Saudi Arabia witnessed the most significant increase in ASR of IE incidence since 1990, while Turkey had the highest rates in 2019. The year 2019 also saw the highest death rate among those aged 70 and over, with over 91000 DALYs from IE. DALYs decreased by 71.5% for children under five from 1990 to 2019 but remained stable for individuals in their seventies. Jordan showed the most notable decrease in ASRs for deaths, DALYs, and YLLs among children under five.

CONCLUSION CONCLUSIONS

This study highlights the changing epidemiology of IE in the NAME region, recommending the establishment of multidisciplinary IE registries, antibiotic prophylaxis guidelines for healthcare-associated IE, and strategies to control antimicrobial resistance as key mitigation measures.

Identifiants

DOI: 10.34172/aim.2024.34 PMID: 38690789

pubmed: 38690789

doi: 10.34172/aim.2024.34

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

229-238

Investigateurs

Elaheh Malakan Rad (E)

Sara Momtazmanesh (S)

Sahar Saeedi Moghaddam (S)

Negar Rezaei (N)

Nazila Rezaei (N)

Mohsen Abbasi-Kangevari (M)

Zeinab Abbasi-Kangevari (Z)

Hedayat Abbastabar (H)

Hassan Abidi (H)

Muhammad Sohail Afzal (M)

Sepideh Ahmadi (S)

Haroon Ahmed (H)

Sami Almustanyir (S)

Jalal Arabloo (J)

Zahra Aryan (Z)

Samaneh Asgari (S)

Mohammadreza Azangou-Khyavy (M)

Sara Bagherieh (S)

Akshaya Srikanth Bhagavathula (AS)

Ali Bijani (A)

Ahmad Daryani (A)

Muhammed Elhadi (M)

Hossein Farrokhpour (H)

Seyyed-Hadi Ghamari (SH)

Ahmad Ghashghaee (A)

Laszlo Göbölös (L)

Mohamad Golitaleb (M)

Mostafa Hadei (M)

Khezar Hayat (K)

Mohammad-Salar Hosseini (MS)

Seyed Kianoosh Hosseini (SK)

Seyed Sina Naghibi Irvani (SS)

Elham Jamshidi (E)

Hamid Reza Koohestani (HR)

Savita Lasrado (S)

Ata Mahmoodpoor (A)

Mohammad-Reza Malekpour (MR)

Yosef Manla (Y)

Ritesh G Menezes (RG)

Yousef Mohammad (Y)

Paula Moraga (P)

Zuhair S Natto (ZS)

Fatemeh Pashazadeh Kan (F)

Akram Pourshams (A)

Mohammad Rabiee (M)

Navid Rabiee (N)

Alireza Rafiei (A)

Sima Rafiei (S)

Samira Raoofi (S)

Sina Rashedi (S)

Sahba Rezazadeh-Khadem (S)

Masoumeh Sadeghi (M)

Farhad Saeedi (F)

Abdallah M Samy (AM)

Parnian Shobeiri (P)

Soraya Siabani (S)

Majid Taheri (M)

Hamed Tavolinejad (H)

Sahel Valadan Tahbaz (S)

Seyed Hossein Yahyazadeh Jabbari (SH)

Mazyar Zahir (M)

Mohammad Zoladl (M)

Hamid Reza Jamshidi (HR)

Mohsen Naghavi (M)

Bagher Larijani (B)

Farshad Farzadfar (F)

Informations de copyright

© 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.